Encompass Health Raises FY2026 Adj EPS Guidance from $5.89-$6.11 to $6.02-$6.25 vs $6.00 Est; Raises FY2026 Sales Guidance from $6.375B-$6.4
Encompass Health (NYSE: EHC ) raises FY2026 Adj EPS guidance from $5.89-$6.11 to $6.02-$6.25 vs $6.00 analyst estimate. Raises FY2026 sales outlook from $6.375 billion-$6.470 billion to $6.410 billion-$6.490 billion vs $6.421 billion estimate.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.